Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused tri and tetra-cyclic pyrazole kinase inhibitors

Fused tri and tetra-cyclic pyrazole kinase inhibitors

US Patent 7320986 · Granted Jan 22, 2008

Estimated economic value: $112,270,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phe2024
Pyrazine compounds as inhibitors of FLT32024
Modulators of the integrated stress pathway2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Polyethylene glycol conjugate drug, and preparation method therefor and use ther2023
Polyethylene glycol conjugate medicament, preparation method therefor and use th2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Antibody-drug conjugates2023
Tricyclic compounds as histone methyltransferase inhibitors2023
Intermediate drug with synergistic anticancer activity and polyethylene glycol-c2022
Prodrug modulators of the integrated stress pathway2021
Antibody-drug conjugates2021